IndraLab

Statements


USP53 activates osteogenic differentiation human bone marrow-derived MSCs. 1 / 1
| 1

eidos
"USP53 inhibits proteasome degradation of beta-catenin by interacting with F-box only protein 31 ( FBXO31 ) , thereby promoting osteogenic differentiation of human bone marrow-derived MSCs ( Baek et al ., 2021 ) ."